Category list : Antineoplastic agents
Sort by: Newest first Oldest first A-Z Z-A
-
Wales will not have a Cancer Drugs Fund, health minister says Subscription
Wales will not have a Cancer Drugs Fund, despite a 98,000-signature petition calling for equity of access to cancer drugs for patients in England and Wales being handed to the Welsh Assembly on 5 November 2014.
-
Vemurafenib shows potential as targeted melanoma therapy
Genetically-targeted chemotherapy combinations based on the BRAF-kinase inhibitor vemurafenib are going on trial for the treatment of metastatic malignant melanoma.
-
Vemurafenib resistance pathway yields targets for melanoma treatment
Researchers from Cancer Research UK have identified a family of proteins that mediate the development of resistance to vemurafenib, a BRAF enzyme inhibitor used to treat patients with advanced melanoma.
-
Treatment tested for patients with visceral leishmaniasis and HIV in Africa Subscription
The efficacy and safety of amphotericin plus miltefosine to treat visceral leishmaniasis patients with HIV will be examined in a Phase III randomized clinical trial in Ethiopia.
-
Teva launches new pegylated filgrastim for reduction of neutropenia
Teva has launched a new pegylated form of filgrastim. It is licensed for reduction of duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy.
-
Temozolomide for melanoma
Temozolomide (Temodal) is as effective as dacarbazine for metastatic melanoma and has the advantage of being an oral preparation, say Dr Mark Middleton (department of medical oncology, Christie hospital NHS trust, Manchester) and colleagues.
-
Targeted oral anti-melanoma therapy dabrafenib set for UK launch
Healthcare professionals will soon be able to add dabrafenib — a targeted oral anti-cancer therapy — to the armoury of medicines available to treat patients with melanoma.
-
Targeted cancer therapy Subscription
Reflection and evaluation are elements of the CPD cycle that pharmacists often find difficult, yet they are integral to producing valid, and rewarding, CPD records.
-
Target high-risk people for melanoma screening
Targeting high-risk individuals for screening could be the best way to improve early detection and treatment of malignant melanoma Alexander Stratigos, of the department of dermatology at the University of Athens Medical School, told the audience during a session at the European Association of Dermatology and Venereology 2010 Spring Symposium.
-
Scientific advances are not translating into new cancer drugs, expert warns Subscription
The global system for discovering new cancer drugs is failing to turn scientific advances into innovative new medicines, Paul Workman, interim chief executive of The Institute of Cancer Research in London has warned.
Show 10 per page20 per page50 per page
